Alzheimer's disease (AD) is a progressive neurodegenerative disorder with clinical manifestations appearing in old age, however, the initial stages of this disease may begin early in life. AD is characterized by the presence of excessive deposits of aggregated β-amyloid (Aβ) peptides, which are derived from the β-amyloid precursor protein (APP) following processing by β-secretase and γ-secretase. Recently, we have reported that developmental exposure of rats to Pb resulted in latent elevation of APP mRNA, APP, and Aβ in old age. Here we examined whether latent up-regulation in APP expression and Aβ levels is exacerbated by concurrent disturbances in APP processing or Aβ aggregation. Among the environmental metals tested, only Aβ solutions containing Pb promoted the formation of Aβ aggregates at nanomolar concentrations. The lifetime profiles of α-, β-, and γ-secretases remained constant in adult and aging animals, and developmental exposure to Pb did not alter them. Furthermore, the addition of various concentrations of Pb (0.1 to 50 μM) to cerebral cortical extracts derived from control animals also did not affect the proteolytic activities of these enzymes. Therefore, we propose that amyloidogenesis is promoted by a latent response to developmental reprogramming of the expression of the APP gene by early exposure to Pb, as well as enhancement of Aβ aggregation in old age. In rodents, these events occur without Pb-induced disturbances to the enzymatic processing of APP. The aforementioned results provide further evidence for the developmental basis of amyloidogenesis and late-life disturbances in AD-associated proteins by environmental agents. lzheimer's disease (AD) is a progressive neurodegenerative disorder whose clinical manifestations appear in old age, however, the initial events that trigger this disease may begin very early in life. The long latency of neurodegenerative diseases such as AD suggests similarities to cancer, in which a significant asymptomatic period (decades) elapses before a progressive accumulation of damage becomes clinically detectable (1). Furthermore, amyloid plaques, the defining hallmark pathological feature of AD, are also present in normal aging individuals, which make it difficult to distinguish this disease at an early stage.
lzheimer's disease (AD) is a progressive neurodegenerative disorder whose clinical manifestations appear in old age, however, the initial events that trigger this disease may begin very early in life. The long latency of neurodegenerative diseases such as AD suggests similarities to cancer, in which a significant asymptomatic period (decades) elapses before a progressive accumulation of damage becomes clinically detectable (1) . Furthermore, amyloid plaques, the defining hallmark pathological feature of AD, are also present in normal aging individuals, which make it difficult to distinguish this disease at an early stage.
The sporadic nature of most AD cases strongly argues for an environmental link that may accelerate normal age-related processes in the brain. Due to the widespread occurrence of AD, such environmental agents (risk factors) would have to be ubiquitous and persistent, and chronic human exposure to them very common. Although few environmental agents may fit this description, the heavy metal Pb is widespread and is known to produce permanent behavioral and cognitive perturbations (2) (3) (4) (5) (6) . The progressive and latent nature of the disease suggests that the triggering event occurs much earlier in time. Therefore, it is important to identify the environmental trigger and to pinpoint the period during which such factors pose the greatest risk. Recently, we reported that developmental exposure of rats to the xenobiotic metal lead (Pb) resulted in a delayed overexpression (20 months later) in β-amyloid precursor protein (APP) mRNA, which was accompanied by an elevation in APP and its amyloidogenic Aβ product (7) . We have also observed that aged monkeys exposed to Pb as infants express higher levels of APP mRNA, APP, and Aβ (unpublished findings). These data suggested that environmental influences occurring during brain development predetermine the expression and regulation of APP later in life, potentially influencing the course of amyloidogenesis, and argue for both an environmental trigger and a developmental origin of AD.
Amyloid plaques are composed primarily of 39-42 residue peptides (Aβ) produced by the proteolytic cleavage of the amyloid precursor protein (APP) (8) . Cleavage of APP by β-secretase produces sAPPβ and C99 fragments. C99 is then cleaved by γ-secretase to release Aβ (8) (9) (10) (11) (12) . However, prior processing of APP by α-secretase precludes the formation of the neurotoxic Aβ. α-Secretase is thought to be a metalloprotease, such as TNF-α converting enzyme (TACE) or a disintegrin and metalloprotease 10 (ADAM10) (13); β-secretase has been characterized as the β-amyloid cleaving enzyme (BACE), a transmembrane aspartyl protease (9, 11, 14, 15) ; and γ-secretase, an atypical aspartyl protease, has not been fully identified to date. Inhibiting α-secretase activity predisposes the processing of APP via the β-secretase pathway, which ultimately leads to neurotoxicity. On the other hand, suppression of β-secretase or γ-secretase activity prevents the formation of the neurotoxic Aβ molecule.
Aβ processing and aggregation are thought to be critical events in the etiology of neurodegenerative diseases such as AD (9, (16) (17) (18) . Mutations in APP have been shown to promote AD pathogenesis in familial AD by altering its proteolytic processing, which results in an increased production of Aβ or increased ratio of Aβ 42 (more amyloidogenic) to Aβ 40 , which tilt the balance toward favoring Aβ aggregation. Similarly, in addition to accelerating neurodegeneration by interfering with the regulation of the APP gene, environmental agents may directly influence the proteolytic processing of APP and/or the dynamics of Aβ aggregation. It has been well established that endogenous metals such as copper (Cu), zinc (Zn), and iron (Fe) play a role in the pathogenesis of AD (19) (20) (21) (22) (23) . Low concentrations of these metals significantly enhance the aggregation of Aβ in vitro. However, the effects of metals on APP processing have not been studied.
The amyloidogenic pathway of APP is determined by the production level of APP (de novo synthesis), the proteolytic breakdown of APP, and the potential production and aggregation of Aβ. We have already determined that developmental exposure to Pb up-regulates the production of APP and its amyloidogenic cleavage products. In the present investigation, we examine whether Pb exposure has an effect on Aβ aggregation as well as the proteolytic processing of APP. 
MATERIALS AND METHODS

Materials
Animal exposure
Timed-pregnant Long-Evans hooded rats were obtained from Charles River Laboratories (Wilmington, MA). Postnatal day 1 (PND 1) was designated as 24 h following birth. All pups were pooled and new litters consisting of 10 males were randomly selected and placed with each dam. The animals were divided into three groups. The control group (Con) received regular tap water. The second group (Pb-E) was exposed to 200 ppm Pb (lead acetate) from PND 1 through PND 20 through the drinking water of the dam. The third group (Pb-L) was exposed to Pb from 18-20 months of age by the addition of 200 ppm Pb to the drinking water. Food and water were available freely throughout the study (4, 8, 24) . The animals were housed individually at an ambient temperature (21±2°C) and relative humidity (50±10%) with a 12 h light/dark cycle (0700-1900 h). On PND 5, 50, 350, and 600 randomly selected pups/adult/senescent animals were decapitated following exposure to carbon dioxide and hypothermia, and brain regions were dissected, frozen on dry ice, and stored at -80°C (filler pups were used to maintain a constant litter size until weaning). The animal exposure protocol and the maintenance of the animal facilities were regularly monitored by the Institutional Animal Care and Use Committee (IACUC) of the University of Rhode Island.
Aβ aggregation
Peptide and Sample Preparation
Aβ (1-40 and 40-1) peptide samples were prepared following the method of Pallitto and Murphy (25) . Each peptide was dissolved in prefiltered (double filtration through 0.22 μm filters) 8 M urea (pH 10) at a concentration of 2.8 mM and diluted with double-filtered (through 0.22 μm filters) phosphate buffered saline to yield a peptide solution with a final concentration of 280 µM (pH 7.4). To initiate aggregation, the peptide was diluted with phosphate buffered saline solution to yield the desired concentration and incubated at 25°C for 4-24 h. The effects of metals on Aβ aggregation were evaluated by comparing the extent of Aβ aggregation in the absence and presence of metals at various concentrations (0.1 and 10 µM) against metal blanks in urea.
Sedimentation assay
The aggregation of Aβ peptide was monitored by sedimentation assay as described by Atwood et al (26) . BSA and Aβ peptide samples were prepared as described above to yield stock solutions at 280 µM. To evaluate the effects of metals, solutions of Ba, Hg, Pb, and Zn (0 µM, 0.1, or 10 µM in the final volume) were added to stock solutions of Aβ or BSA. The final concentration of Aβ was then brought to 70 µM in phosphate buffered saline (pH 7.4), and the samples were incubated at 37°C for 30 min in micro-centrifuge tubes. To determine the amount of Aβ aggregates formed in the presence and absence of metals, the incubated peptide solutions were spun at 10,000 × g for 20 min to sediment any Aβ aggregated particles formed, and the amount of soluble protein remaining in the supernatant was then determined using the BCA microprotein assay.
Bis-ANS fluorescence assay
Aβ aggregation was further evaluated using the bis-ANS fluorescence assay as described by Pallitto and Murphy (25) . 4,4'-dianilino-1,1'-binapthyl-5,5′-disulfonic acid (bis-ANS) is a hydrophobic dye that has been shown to bind to the partly folded peptides. Aβ solutions were prepared as described above and incubated in the presence and absence of metals. The final concentration of the samples were adjusted to 2 µM Aβ with phosphate buffered saline (pH 7.4) while transferring to a 96-well plate. Then bis-ANS (20 µM in the final volume) was added to the reaction mixture and incubated in the dark for 4 min. The fluorescence emission of bis-ANS was measured at 530 nm (λexcitation=360 nm) using a fluorimeter (Packard Instruments, Meriden, CT).
Secretase activity assay
The activity levels of α, β, and γ secretases were measured using the kits obtained from R&D Systems, Inc. The tissue lysates, prepared in the extraction buffer (provided by the suppliers), were tested for secretase activity by the addition of a secretase-specific peptide conjugated to the reporter molecules EDANS and DABCYL. In the uncleaved form, the fluorescent emissions from EDANS are quenched by the physical proximity of the DABCYL moiety, which exhibits maximal absorption at the wavelength of 495 nm. Cleavage of the peptide by secretase physically separates the EDANS and DABCYL, allowing for the release of a fluorescent signal. The level of secretase enzyme activity in the sample is proportional to the fluorescence. Using the above protocol, rat cerebral cortices were homogenized in 1× extraction buffer (R&D kit) and incubated on ice for 10 min. The homogenates were then centrifuged at 10,000 × g for 1 min at 4°C. The protein concentration in each sample was estimated according to the protocol of Pierce Biotechnology, Inc. The experiments were optimized with various concentrations of the tissue lysate using rhTACE (R&D Systems) as a positive control. Protein concentrations of 1-2 mg/mL were used in all experiments as per the manufacturer's instructions.
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The assays were set up in sterile 96-well plates using the tissue homogenates prepared from the cerebral cortices as described above using the reagents provided in the kit. The tissue lysates were incubated in the dark for 2 h at 37°C along with 50 μL of 2X reaction buffer and 5 μL of substrate. Specific kits were used for measuring α-, β-, and γ-secretase activity. Following incubation, the plates were analyzed for fluorescence [355 nm (excitation) and 500 nm (emission)]. To observe the in vitro effects of Pb on secretase activity, we conducted experiments using the cell lysates prepared from PND 5 rat cortical tissue. Various concentrations of Pb (0, 0.1, 1, 10, and 50 μM) were added to the cell lysates and the plates were analyzed by fluorescence as described above using specific R&D kits for α-, β-, and γ-secretase activities.
Statistical treatment
Data were analyzed by two-way ANOVA and followed by Duncan's post-hoc test to compare the effects among various groups. Values marked with an asterisk (*) are significantly different from their corresponding controls at 5% level of significance.
RESULTS
Aβ aggregation studies
Increased APP expression and/or processing are known to accelerate AD pathogenesis in humans and animal models of AD, due to the increased production of the amyloidogenic peptides Aβ and Aβ . Therefore, chemically induced transcriptional perturbations leading to increased APP levels are likely to result in increased levels of Aβ, thus favoring Aβ aggregation. Alternatively, environmental agents could exacerbate the situation by directly promoting Aβ aggregation and plaque formation. Since the Aβ sequence in rodents varies by three amino acids from that of primates, it does not deposit or form plaques in rodents. Therefore, we sought to examine the effects of xenobiotic metals on human Aβ aggregation in vitro.
Using the sedimentation assay, we observed that Pb and Zn promoted Aβ 1-40 aggregation (25-28% and 30-35% increase respectively by Pb and Zn), whereas Ba and Hg had minimal effects (Fig. 1A) . Zn has been shown to accelerate Aβ aggregation in vitro (27) and was used in these experiments as a positive control, whereas Ba and Hg were included as negative controls to demonstrate that promotion of Aβ aggregation by Pb is not a generalized response of the peptide to the presence of metals. It was also important to show that the actions of these metals do not necessarily promote protein aggregation. Therefore, we repeated these protein estimation experiments using BSA. We found that none of the above metals promoted the aggregation of BSA (Fig. 1B) .
The fluorescent dye bis-ANS was used to probe the conformational properties of Aβ and Aβ aggregates in the absence and presence of metals at various concentrations. Bis-ANS is known to bind aggregated but not monomeric Aβ. Therefore, the non-amyloidogenic Aβ 40-1 was used as a control in these experiments. Only Aβ solutions containing Pb or Zn were observed to bind tightly to bis-ANS, consistent with the presence of Aβ aggregates, as determined by the sedimentation assay (Fig. 2) . The aggregation patterns observed using this method displayed dose-dependence when analyzed by an ANOVA followed by a Duncan's post-hoc test. These findings were similar to those of the preliminary screens we performed using the Thioflavin T binding assay (28) . Solutions containing Aβ 40-1 or BSA (data not shown) either in the presence or absence of Pb or Zn did not show any increase in bis-ANS fluorescence. However, the higher sensitivity and specificity of this fluorescence technique revealed a greater effect of selected metals on aggregation (~20 and ~100% increase, respectively, for 0.1 and 10 μM of Pb; ~85 and ~200%, respectively, for 0.1 and 10 μM of Zn).
APP proteolysis
We profiled the cortical activity levels of α-, β-, and γ-secretase across the lifespan of rodents. We found that the activities of α-and γ-secretases peaked during early brain development and then decreased to basal levels in adulthood and remained constant for the rest of the animals' lives (Fig. 3) . We examined the effects of Pb-exposure at 20 months of age on the activity of each secretase using cortical tissue from three different groups: Control, Pb-E (exposed to 200 ppm Pb in drinking water from birth to weaning), and Pb-L (exposed to 200 ppm Pb in drinking water from 18-20 months). We found no significant changes in the activity levels of any of the three enzymes among the groups tested (Fig. 4) .
To examine whether higher concentrations of Pb would interfere with these enzymes, we performed in vitro studies using cell lysates prepared from PND 5 control rat cortices. The cell lysates were incubated with a wide range of Pb concentrations (0, 0.1, 1, 10, and 50 μM) and assayed for activity levels of α-, β-, and γ-secretases. Similar concentrations of Cu in a pilot study also had no effect on β-secretase activity (data not shown). Ca was used as a control metal in these experiments. The results showed that neither Pb nor Ca (used as control) affected the activity of the three secretases (Table 1) .
DISCUSSION
The contribution of environmental factors to disease processes is becoming increasingly evident. Heavy metals such as Pb pose widespread public concern. Humans can be exposed to Pb through paint, glazed earthenware, lead piping, solder in food containers, moonshine whiskey, and automobile battery casings (29) . Occupational exposure to Pb can come from smelters, battery manufacturing, welding, automobile radiator repair, and production of Pb-based paints. Although organic forms of Pb have been removed from gasoline, inorganic Pb still remains the number one environmental hazard facing humans today. Many endogenous metals such as zinc, copper, iron, and manganese are suspected to contribute to the pathogenesis of AD. However, few studies have focused on heavy metals that are not part of cellular factors (30) (31) (32) (33) (34) (35) . Previous studies have shown the contribution of endogenous metals such as Zn in Aβ aggregation and also the formation of amyloid plaques in transgenic mice brains (26, 27, (35) (36) (37) (38) . We have used the rat model to study the effect of Pb on APP, Aβ (7) and enzymes involved in APP proteolysis. We did not find Aβ deposits in this animal model due to Pb-exposure. While elevation in rat APP was translated into increased Aβ levels (7), the Aβ does not deposit or form plaques partially due to differences in the amino acid sequence. Hence, we have used a synthetic human Aβ peptide to determine whether the presence of Pb would impact its aggregation properties. Our findings that Pb promotes Aβ sedimentation at nanomolar concentrations (Fig. 1) suggested that environmental exposure to heavy metals is a potential risk factor for amyloidogenesis. Our results agree with previously published work for other metals such as Al, Cu, and Zn (26, 27, 39) . Although studies on Zn showed significant effects on aggregation at pH 6.0, we found Pb as a potent agent in promoting aggregation at the physiological pH 7.4.
Aβ aggregation was monitored further by the fluorescent method using bis-ANS. This assay has been previously used to characterize the aggregation of Aβ (25, 40). Although we used two different assays to quantify the promotion of aggregation, we are uncertain as to the biophysical properties of aggregates formed by Pb. Detailed studies to understand the exact nature of products formed in the aggregation by Pb are currently under investigation using the electron microscopic (EM) technique. The Pb levels used in vitro (0.1-10 µM) are similar to the brain tissue burden of 0.32 µg/g of tissue. In vitro we used a v/v ratio of 1 × 10 −5 to 1 × 10 −7 , which compares to the in vivo w/w ratio of 3.2 × 10 −7 . However, while the concentrations are comparative, the in vivo studies were conducted in rodents whereas the in vitro experiments used human Aβ. On the one hand, rodent Aβ does not aggregate and deposit. On the other hand, the sequence characteristics of human Aβ predisposes it to aggregation in the presence of metals (35) . It can thus be speculated that if the in vivo exposure occurred in a plaque-forming animal, it would be expected to result in Aβ deposition an aggregation.
The developmental and lifelong activities of α-, β-, and γ-secretase in control animals mirror our recently reported studies with APP expression. However, γ-secretase is the only enzyme that is highly active during the developmental period. The increase in gamma secretase activity is statistically significant at PND 5. This is consistent with previous studies demonstrating that Aβ levels are higher in the prenatal brain and Aβ might have an important role in development (41, 42) .
Although Pb acts to enhance Aβ aggregation in vitro, our in vivo and in vitro studies show that Pb does not influence the activities of the α-, β-, and γ-secretase enzymes that participate in APP processing, although the tissue Pb concentration (cortex Pb=0.32±0.03 µg/g wet wt. of tissue) was significantly high (7). However, while developmental exposure to Pb increases Aβ as well as APP levels (7), it does not seem to have an effect on the secretases. It is our interpretation that the activity of these enzymes is high and therefore is not overwhelmed by the increases in APP levels; however, regulation of secretase enzymes, such as BACE (43), remains to be studied under the developmental context.
Finally, the long latency of AD suggests that this neurodegenerative disease remains asymptomatic for decades before a progressive accumulation of damage becomes clinically detectable. Our findings suggest that the initial events that trigger this disease begin very early in life and may be worsened by re-exposure to environmental agents late in life. Therefore, we propose that amyloidogenesis is promoted by a latent response to developmental reprogramming of the expression of the APP gene by early exposure to Pb, as well as enhancement of Aβ aggregation in old age. In rodents, these events occur without Pb-induced disturbances to the enzymatic processing of APP. The above-described findings provide further evidence for the developmental basis of amyloidogenesis and late-life disturbances in AD-associated proteins by environmental agents. Effect of in vitro addition of Pb or Ca on α-, β-, and γ-secretase activities. Cortical homogenates from 5-day-old rats were prepared and incubated with 0, 0.1, 1.0, 10, and 50 µM Pb or Ca and were analyzed for the activity levels of α-, β-, and γ-secretases using the R&D Systems kit as described in Materials and Methods. Each data point represents the mean ± SEM (n=4-6).
Page 12 of 16 (page number not for citation purposes) Brain homogenates were prepared from these tissues and analyzed for the activity levels of α-, β-, and γ-secretases using the R&D Systems kit as described in Materials and Methods. The intensity of fluorescence was used as a measure of enzyme activity. Each data point represents the mean ± SEM (n=4-6). 4 . Effect of developmental and old age exposure to Pb on the activity levels of α-, β-, and γ-secretases in the cortex. Animals were exposed to 200 ppm Pb-acetate (Pb-E: birth through weaning; Pb-L:18-20 months of age). Brain cortices were obtained from 20-month-old Control, Pb-E, and Pb-L animals. Brain homogenates were prepared from these tissues and assayed for the activity levels of α-, β-, and γ-secretases using the R&D Systems kit as described in Materials and Methods. The intensity of fluorescence was used as a measure of enzyme activity. Each data point represents the mean ± SEM (n=4-6). Blood and tissue levels of Pb are shown in the insert. Values marked with an '*' are significantly different from their corresponding controls (P<0.05).
